MARKET

LXRX

LXRX

Lexicon Pharmaceuticals Inc
NASDAQ
2.190
+0.210
+10.61%
After Hours: 2.190 -0.001 -0.02% 19:37 03/27 EDT
OPEN
2.000
PREV CLOSE
1.980
HIGH
2.290
LOW
1.992
VOLUME
5.17M
TURNOVER
0
52 WEEK HIGH
3.789
52 WEEK LOW
0.9200
MARKET CAP
539.26M
P/E (TTM)
-2.7341
1D
5D
1M
3M
1Y
5Y
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
LuxUrban Hotels shares dipped 27.4% to $1.5523 on Wednesday. The company issued preliminary fourth-quarter revenue outlook below estimates. MariaDB plc shares climbed 70.4%. Lixte Biotechnology Holdings, Inc. Shares jumped 68.6% in mid-day session.
Benzinga · 22h ago
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
Shares of Cintas Corporation jumped 9.7% to $694.62 on Wednesday. The company reported better-than-expected third-quarter financial results and raised FY24 guidance. PaySign, Inc. Shares jumped 28.2% after the company announced better- than-expected fourth-quarter results. Dow Jones index gained around 300 points in Wednesday's session.
Benzinga · 1d ago
WPRT, FIVN and FATE are among after hour movers
On the Move WPRT, FIVN and FATE are among after hour movers. Stoke Therapeutics (STOK) and AnaptysBio (ANAB) are among the Gainers. Westport Fuel Systems (WPRT) and Five9 (FIVN) are losers.
Seeking Alpha · 2d ago
Lexicon Pharmaceuticals files to sell 57.66M shares for holders
Lexicon Pharmaceuticals files to sell 57.66M shares for holders Mar. 25, 2024. The company filed a prospectus related to the proposed resale of 57. 66M shares by selling stockholders. This prospectus is not an offer to sell these securities.
Seeking Alpha · 2d ago
Lexicon Pharmaceuticals Announces Clinical Data On The Impact Of Sotagliflozin On Stroke And Heart Attack Risk Among Four Lexicon-Sponsored Presentations At The American College Of Cardiology 73rd Annual Scientific Session & Expo
Four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport proteins, will be delivered during the American College of Cardiology 73rd Annual Scientific Session & Expo in Atlanta, 2024. The presentations include results from a post-hoc evaluation of the efficacy of the drug in reducing stroke events in patients with type 2 diabetes, chronic kidney disease and high cardiovascular risk.
Benzinga · 3d ago
Weekly Report: what happened at LXRX last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at LXRX last week (0311-0315)?
Weekly Report · 03/18 09:23
Analysts’ Top Healthcare Picks: REPRO-MED Systems (KRMD), Catalyst Pharma (CPRX)
TipRanks · 03/14 11:20
More
About LXRX
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its pipeline includes Sotagliflozin, LX9211, and LX2761. Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. Its LX2761 is an orally-delivered small molecule compound that is designed to inhibit sodium-glucose cotransporter 1 (SGLT1) locally in the gastrointestinal tract without any inhibition of SGLT2 in the kidney.

Webull offers Lexicon Pharmaceuticals Inc stock information, including NASDAQ: LXRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LXRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LXRX stock methods without spending real money on the virtual paper trading platform.